Alta Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85190MH1954PLC009215 Incorporated 21 January 1954 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2023
₹157.29 Cr
▼ 7% YoY
Net profit · FY 2023
₹13.5 Cr
Net margin 8.6%
EBITDA · FY 2023
₹16.17 Cr
EBITDA margin 10.3%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹59.94 Cr
Company age
72 yrs
Est. 1954
Employees · EPFO
181
Provident fund records

About Alta Laboratories Limited

Data last updated:

Alta Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 January 1954 and has been in existence for over 72 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85190MH1954PLC009215. Its GSTIN is 27AAACA1012B1ZQ (Maharashtra).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Jayant Ramhari Dhote (Managing Director) and Nirupa Kiran Bhatt.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aita Bhavan 532 Senapati Bapat Marg Dadar (W), Mumbai, Maharashtra, India – 400028.

As per the financials filed for FY 2023, the company reported a revenue of ₹157.29 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹13.5 Cr (net margin 8.6%) and EBITDA of ₹16.17 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 5% over five years.

The company has about 181 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Alta Laboratories and Alta Laboratories Ltd. As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹59.94 Cr on record. Court records list 18 cases involving the company, including 9 filed by the company and 9 filed against it; 6 cases are pending. The company has 16 deals on record (15 secondary share transfers, 1 funding round), with disclosed funding of ₹1.98 Cr; the latest was in March 2024.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alta.in.

Company details

CIN U85190MH1954PLC009215
Registration Number 009215
Incorporation Date 21 January 1954
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Alta Laboratories has one previous CIN (Corporate Identification Number): L85190MH1954PLC009215. The current CIN is U85190MH1954PLC009215, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85190MH1954PLC009215Current
L85190MH1954PLC009215Previous

Contact details

Alta Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is alta.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    Aita Bhavan 532 Senapati Bapat Marg Dadar (W), Mumbai, Maharashtra, India – 400028
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Alta Laboratories Limited, buy the company report.

Comprehensive company report
Alta Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Alta Laboratories operates two associated brands: Alta Laboratories and Alta Laboratories Ltd. Each brand links to its own profile.

BrandDescriptionWebsite
Produces high-quality salicylic acid and derivatives for global industries.alta.in
Manufacturing of chemical products such as Salicylic Acid and related compounds in India.altaroma.in

Financials of Alta Laboratories Limited

FY 2025 filings available

Alta Laboratories Limited reported revenue of ₹157.29 Cr (down 7% YoY) for FY 2023.

Revenue · FY 2023
₹157.29 Cr ▼ 7%
Net profit · FY 2023
₹13.5 Cr margin 8.6%
EBITDA · FY 2023
₹16.17 Cr margin 10.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 5%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 35%
5 years · compounded
▼ 2%

Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹157.29 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.17 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹13.5 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin10.3%
Net Profit Margin8.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alta Laboratories Limited, buy the company report.

Board of directors of Alta Laboratories Limited

Alta Laboratories has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nirupa Kiran BhattDirector03 Sep 20215 Years 1 MonthsCurrent
Jayant Ramhari DhoteManaging Director11 Aug 197848 Years 2 MonthsCurrent
Geeta Jayant DhoteDirector15 Feb 20206 Years 8 MonthsCurrent
Anita ReddyDirector15 Feb 20206 Years 8 MonthsCurrent

Auditor

Alta Laboratories Limited is audited by G. D. Apte & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
G. D. Apte & Co.FY 2023100515W

Shareholding

The shareholding of Alta Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alta Laboratories Limited, buy the company report.

Charges & borrowings

Open charges
₹6 Cr
Satisfied charges
₹59.94 Cr
Breakdown by lending institutions
Others₹26.00 Cr
The Cosmos Co-Op Bank Ltd₹18.12 Cr
Bank of Maharashtra₹9.78 Cr
The United Western Bank Ltd.₹5.15 Cr
The Cosmos Co- Operative Bank Ltd₹0.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Dec 2024101016193Others₹3 CrSatisfied
01 Mar 2023100691732Others₹3 CrSatisfied
11 Jul 2022100597476Others₹3 CrSatisfied
06 Jun 2022100584800Others₹1 CrSatisfied
11 Apr 2022100563239Others₹1 CrSatisfied

To see the full charge records of Alta Laboratories Limited, buy the company report.

Total charge records: 34 View all charges

Deals & funding

Alta Laboratories Limited has 16 deals on record (15 secondary share transfers, 1 funding round), with disclosed funding of ₹1.98 Cr; the latest was in March 2024.

Total deals
16
Secondary share transfers
15
Funding round
1
Disclosed funding
₹1.98 Cr

Deals on record (5 of 16)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedSeller: J&S Investments Private Limited, Altona Investments Private Limited
Mar 2017Secondary share transferUndisclosedBuyer: Altona Investments Private Limited
Seller: Jayant Ramhari Dhote Huf, an individual
Mar 2012Secondary share transferUndisclosedBuyer: Ramhari Foundation, 2 individuals
Seller: Altona Investments Private Limited , an individual
Mar 2011Secondary share transferUndisclosedBuyer: J&S Investments Private Limited, Altona Investments Private Limited
Seller: Aspy Investments Pvt Ltd , R K Dhote P C Trust, T R Dhote Pub Charitable Trust
Mar 2010Secondary share transferUndisclosedBuyer: R K Dhote P C Trust, Ramhari Investments Pvt Ltd , T R Dhote Pub Charitable Trust
Seller: J&S Investments Private Limited, Altona Investments Private Limited , Ramhari Foundation

To see the full deal history of Alta Laboratories Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Alta Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Alta Laboratories Limited has a workforce of 181 employees on its EPFO records as of Aug 12, 2024, across 2 active EPFO establishments.

Employee count
181
Active EPFO establishments
2
Employee growth
2.26%

GST

Alta Laboratories has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACA1012B1ZQMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Alta Laboratories Limited, buy the company report.

Recent activity

Alta Laboratories Limited has 12 board changes on record since 1978: 4 appointments and 8 cessations. The latest: Sanjay Ramhari Dhote ceased to be Director on 30 Sep 2025.

Charges
A charge registered on 03 Dec 2024 via Charge ID 101016193 with Others was fully satisfied on 10 Nov 2025.
Charges
A charge registered on 01 Mar 2023 via Charge ID 100691732 with Others was fully satisfied on 10 Nov 2025.
Charges
A charge with Others of Rs. 3.00 Cr registered on 03 Dec 2024 with Charge ID 101016193 was modified on 01 Nov 2025.
AGM
Alta Laboratories Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Sanjay Ramhari Dhote ceased to be Director.
Filing
Alta Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 11 Jul 2022 via Charge ID 100597476 with Others was fully satisfied on 11 Feb 2025.
Charges
A charge registered on 06 Jun 2022 via Charge ID 100584800 with Others was fully satisfied on 11 Feb 2025.
Charges
A charge registered on 11 Apr 2022 via Charge ID 100563239 with Others was fully satisfied on 11 Feb 2025.
Charges
A charge registered on 27 Nov 2021 via Charge ID 100507425 with Others was fully satisfied on 11 Feb 2025.
Charges
A charge registered on 19 Mar 2021 via Charge ID 100431349 with Others was fully satisfied on 11 Feb 2025.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101016193 was registered on 03 Dec 2024.

78 earlier events are in the company report.

Frequently asked questions

Alta Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 January 1954 (72+ years old) and is registered under CIN U85190MH1954PLC009215.

Alta Laboratories has 4 current directors:

The latest financial statements of Alta Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Alta Laboratories is 27AAACA1012B1ZQ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Alta Laboratories is U85190MH1954PLC009215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alta Laboratories has 18 court cases on record: 9 filed by the company and 9 filed against it. 6 are pending. Most are in the high courts.

Alta Laboratories was incorporated on 21 January 1954, making it 72+ years old. It is registered with the Registrar of Companies, Mumbai.

Alta Laboratories has 16 deals on record (15 secondary share transfers, 1 funding round), with disclosed funding of ₹1.98 Cr; the latest was in March 2024.

Sanjay Ramhari Dhote ceased to be Director on 30 Sep 2025. Nirupa Kiran Bhatt ceased to be Additional Director on 27 Sep 2021. Vikram Jaisingh Chavan ceased to be Director on 27 Sep 2021. Alta Laboratories has 12 board changes on record in total.

Alta Laboratories can be reached through the website alta.in. Its registered office is in Mumbai, Maharashtra, India.